Long chain lipid based tamoxifen NLC. Part II: Pharmacokinetic, biodistribution and in vitro anticancer efficacy studies

Harshad Shete(University of Mumbai), Sushmita Chatterjee(Advanced Centre for Treatment, Research and Education in Cancer), Abhijit De(Advanced Centre for Treatment, Research and Education in Cancer), Vandana Patravale(Institute of Chemical Technology)
International Journal of Pharmaceutics
March 25, 2013
10.1016/j.ijpharm.2013.03.036
Cited by 82

Abstract

Related Papers

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Mihaela Skobe, Thomas Hawighorst, David G. Jackson et al.|Nature Medicine|2001|1.7k
Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system
Fuqiang Hu, Saiping Jiang, Yongzhong Du et al.|Colloids and Surfaces B Biointerfaces|2005|506
Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery
R.H. Müller, W. Mehnert, J.S. Lucks et al.|European Journal of Pharmaceutics and Biopharmaceutics|1995|457
VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells
Petri Salvén, Satu Mustjoki, Riitta Alitalo et al.|Blood|2002|378
Establishment and characterization of three new continuous cell lines derived from human breast carcinomas.
Linda W. Engel, Nathaniel A. Young, Tommie Sue Tralka et al.|PubMed|1978|376